Deargen applied patent for a novel target compound candidate.
Read More
Technical & News Articles about Deargen
Deargen applied patent for a novel target compound candidate.
Read MoreDeargen collaboration with Samsung Seoul Hospital, to discover new Alzheimer’s treatments using AI technology.
Read MoreAt ACM CHIL 2021, Deargen presented study results on a model of simultaneously optimizing multiple properties of molecules.
Read MoreDeargen: Laveraging AI to Accelerate New Drug Development.
Read MoreDeargen and Uptera selected two target proteins, including anti-cancer drugs, and signed a joint research contract.
Read MoreAI-based Drug Discovery, What would be the limitation?
Read MoreHANDOK and Deargen will conduct joint researches on “oncology” and other diseases using DearDTI.
Read MoreDeargen collaboration with IN Therapeutics collaboration to develop a treatment for hearing loss.
Read MoreSKChemical and Deargen will conduct joint researches on “drug repositioning” and “de novo drug design.”
Read MoreDeargen to attract 3 billion won for pre series A, recruited CBO Youngchul Bae
Read More